Valuation : Mega Lifesciences

Market Cap 31.39B 955M 820M 767M 703M 1.32B 91.2B 1.33B 9.09B 3.55B 45.97B 3.59B 3.51B 152B P/E 2026 *
13.3x
P/E 2027 * 12.6x
Enterprise Value 26.77B 814M 699M 655M 599M 1.13B 77.79B 1.13B 7.75B 3.03B 39.2B 3.06B 2.99B 130B EV / Sales 2026 *
1.87x
EV / Sales 2027 * 1.7x
Free-Float
38.61%
Yield 2026 *
4.89%
Yield 2027 * 5.27%
1 day+0.68%
1 week-1.33%
Current month-2.63%
1 month-0.67%
3 months+6.47%
6 months+1.37%
Current year+10.45%
1 week 36.25
Extreme 36.25
37.5
1 month 36.25
Extreme 36.25
39.75
Current year 31.5
Extreme 31.5
40
1 year 27.75
Extreme 27.75
40
3 years 24.3
Extreme 24.3
46.75
5 years 24.3
Extreme 24.3
56.5
10 years 17.6
Extreme 17.6
56.5
Manager TitleAgeSince
Chief Executive Officer 64 01/01/1988
Director of Finance/CFO 62 01/01/1997
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 62 01/01/1998
Director/Board Member 64 01/01/2013
Director/Board Member 73 01/02/2013
Date Insider Type Main position Quantity % Market Cap.
4/29/25 A Buy

Chief Executive Officer

100,000 0.0115%
4/28/25 A Buy

Chief Executive Officer

50,000 0.0057%
4/28/25 A Buy

Chief Executive Officer

150,000 0.0172%
Change 5-day change 1-year change 3-year change Capi.($)
+0.68%-1.33%+24.37%-12.43% 949M
-0.45%-4.88%+61.22%+113.69% 1,060B
-1.22%-0.10%+51.09%+62.58% 651B
-1.78%-1.23%+24.30%+75.42% 465B
-1.17%-2.10%+38.61%+40.46% 365B
-2.00%-1.35%+22.22%+37.78% 300B
-0.98%+0.53%+2.04%+12.13% 258B
-0.09%+1.45%+52.80%+71.52% 238B
-3.18%-0.30%-17.23%-54.33% 210B
+0.22%+3.67%+30.53%+93.02% 184B
Average -0.94%-0.46%+29.00%+43.98% 373.14B
Weighted average by Cap. -1.03%-2.15%+38.94%+66.52%

Financials

2026 *2027 *
Net sales 14.35B 436M 375M 351M 321M 605M 41.69B 607M 4.15B 1.62B 21.01B 1.64B 1.6B 69.54B 15.66B 477M 409M 383M 351M 661M 45.52B 663M 4.54B 1.77B 22.94B 1.79B 1.75B 75.92B
Net income 2.23B 67.87M 58.26M 54.54M 49.94M 94.08M 6.48B 94.35M 646M 252M 3.27B 255M 249M 10.81B 2.49B 75.61M 64.91M 60.77M 55.64M 105M 7.22B 105M 720M 281M 3.64B 284M 278M 12.05B
Net Debt -4.62B -140M -121M -113M -103M -195M -13.41B -195M -1.34B -523M -6.76B -527M -516M -22.38B -4.72B -144M -123M -115M -106M -199M -13.71B -200M -1.37B -534M -6.91B -539M -527M -22.88B
Logo Mega Lifesciences
Mega Lifesciences Public Company Limited is a Thailand-based company, which is engaged in health and wellness industry. Its segments include Brands, Distribution and OEM. MEGA We Care is its branded products business, through which it develops, manufactures, markets and sells its own range of nutraceuticals, complementary medicines, prescription pharmaceuticals and over the counter (OTC) health products. Maxxcare serves as its prominent distribution arm, specializing in the marketing, sales, and distribution of a range of branded prescription pharmaceuticals, OTC medications and fast-moving consumer goods (FMCG) across key markets such as Myanmar, Vietnam and Cambodia. Its suite of services encompasses warehouse management, collections and value-added initiatives, including tailored marketing services for principals in the pharmaceutical and FMCG sectors. Its manufacturing facilities in Thailand, Australia and Indonesia also accept production orders from various third-party customers.
Employees
-
Date Price Change Volume
27/08/26 THB 36.00 +0.70% 473,482
26/08/26 THB 35.75 -3.38% 1,355,674
25/08/26 THB 37.00 +0.68% 446,014
24/08/26 THB 36.75 -0.68% 568,501
21/08/26 THB 37.00 +0.68% 629,651
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
36.00THB
Average target price
42.71THB
Spread / Average Target
+18.65%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEGA Stock